Avidity Partners Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-466,800
Closed -$8.5M 80
2024
Q3
$8.5M Sell
466,800
-297,400
-39% -$5.67M 0.43% 60
2024
Q2
$13.3M Hold
764,200
0.56% 59
2024
Q1
$15M Sell
764,200
-522,800
-41% -$11M 0.48% 57
2023
Q4
$29.6M Sell
1,287,000
-258,100
-17% -$5.78M 1.08% 42
2023
Q3
$35.5M Buy
1,545,100
+465,294
+43% +$11.8M 1.43% 33
2023
Q2
$28.2M Buy
+1,079,806
New +$28.5M 0.98% 41

Other funds holding PRVA

Avidity Partners Management's PRVA Position: Q4 2024 in Review

Avidity Partners Management sold out of Privia Health (PRVA) in Q4 2024, closing a stake of 466,800 shares — an estimated $8.5M sold.

Avidity Partners Management first reported a position in PRVA in Q2 2023 and held it in 6 quarters. The position peaked at $35.5M in Q3 2023. 231 funds tracked by Wall St. Rank hold PRVA as of Q4 2024.

  • Avidity Partners Management reported no remaining Privia Health position as of Q4 2024 after selling out during the quarter.
  • Avidity Partners Management sold 466,800 Privia Health shares in Q4 2024, an estimated $8.5M.
  • Avidity Partners Management first reported a position in Privia Health in Q2 2023 and held it in 6 quarters.
  • Avidity Partners Management's Privia Health position peaked at $35.5M in Q3 2023.
  • 231 funds tracked by Wall St. Rank held Privia Health as of Q4 2024.

Based on Avidity Partners Management's 13F filing for Q4 2024, filed 14 Feb 2025.